Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Albert M. Kligman made major contributions to dermatology, including inventing a stain for fungi and advancing knowledge on skin diseases, and his legacy continues through his trainees and philanthropy.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

The document says biodegradable cosmetics and packaging are better for the environment and user experience.

FFA in men shows unique features and treatment results vary widely.

Australian dermatologists are updating their prescriptions for male pattern baldness.

Systemic minoxidil might help maintain hair regrowth in alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Drug companies were interested in advertising directly to consumers to make back their money, but most didn't think it would help and were concerned about negative effects.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Microemulsions could improve how drugs are delivered and absorbed in the body.

SET7/9 enzyme affects cell growth and diseases like cancer, diabetes, and obesity.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

The Trichoscan system was found to be inaccurate for measuring hair growth, needing better software to be useful.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Southeast Asian herbs show promise for skin and hair care, but more research is needed to confirm their effectiveness in cosmetics.